Education
About Us
Working with TipRanks
Follow Us
Hospital Corporation of China Ltd (HK:3869)
:3869
3869 Stock Chart & Stats
HK$5.80
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.80
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$3.12 - HK$7.55
Previous CloseN/A
Volume10.00K
Average Volume (3M)660.00
Market Cap
HK$710.32M
Enterprise ValueHK$1.03B
Total Cash (Recent Filing)HK$723.01M
Total Debt (Recent Filing)HK$1.02B
Price to Earnings (P/E)4.9
Beta0.05
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding138,194,000
10 Day Avg. Volume1,420
30 Day Avg. Volume660
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)2.59
Price to Sales (P/S)0.61
P/FCF Ratio4.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth, even if modest, indicates ongoing demand for the group’s clinical services and supports utilization gains across hospitals. Over the next 2–6 months this revenue trend underpins scale economics and provides a base for margin recovery and reinvestment in services.
Improving Gross And EBITDA Margins; Healthy EBITRising gross and EBITDA margins plus a resilient EBIT margin indicate improved pricing or operational efficiency in core hospital operations. These margin gains are durable drivers of future cash generation potential if sustained, helping to offset pressure from financing costs once leverage is addressed.
Hospital Network Business Model And ScaleOperating a network of hospitals and integrated medical services creates recurring revenue streams, referral flows, and opportunities to centralize back-office functions. The platform model supports long-term patient volume capture and service expansion, a structural advantage for durable growth and margin improvement.
Bears Say
Negative Net Income And ROEA net loss and negative return on equity erode shareholder capital and constrain retained earnings available for reinvestment. Persisting losses can exacerbate funding needs, weaken stakeholder confidence, and make it harder to deleverage or fund expansion without external capital over the medium term.
High Leverage And Weak Equity BaseVery high leverage and a low equity ratio raise refinancing and interest-coverage risk, limiting financial flexibility. In a capital-intensive hospital business this amplifies downside in stress scenarios and can force conservative investment pacing or costly refinancing if cash flows do not improve.
Zero Operating And Free Cash Flow In 2024Lack of operating cash flow undermines the firm’s ability to service debt, fund capex, or support working capital without external financing. This is a persistent liquidity constraint that can necessitate asset sales, equity raises, or debt restructuring if operating cash generation does not recover sustainably.
Hospital Corporation of China Ltd News
3869 FAQ
What was Hospital Corporation of China Ltd’s price range in the past 12 months?
Hospital Corporation of China Ltd lowest stock price was HK$3.12 and its highest was HK$7.55 in the past 12 months.
What is Hospital Corporation of China Ltd’s market cap?
Hospital Corporation of China Ltd’s market cap is HK$710.32M.
When is Hospital Corporation of China Ltd’s upcoming earnings report date?
Hospital Corporation of China Ltd’s upcoming earnings report date is Mar 30, 2026 which is in 35 days.
How were Hospital Corporation of China Ltd’s earnings last quarter?
Hospital Corporation of China Ltd released its earnings results on Aug 27, 2025. The company reported HK$1.21 earnings per share for the quarter, beating the consensus estimate of N/A by HK$1.21.
Is Hospital Corporation of China Ltd overvalued?
According to Wall Street analysts Hospital Corporation of China Ltd’s price is currently Overvalued.
Does Hospital Corporation of China Ltd pay dividends?
Hospital Corporation of China Ltd does not currently pay dividends.
What is Hospital Corporation of China Ltd’s EPS estimate?
Hospital Corporation of China Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hospital Corporation of China Ltd have?
Hospital Corporation of China Ltd has 138,194,000 shares outstanding.
What happened to Hospital Corporation of China Ltd’s price movement after its last earnings report?
Hospital Corporation of China Ltd reported an EPS of HK$1.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hospital Corporation of China Ltd?
Currently, no hedge funds are holding shares in HK:3869
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hospital Corporation of China Ltd
Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi Hospital, and Jinhua Hospital; and general hospital services. It also engages in the wholesale of pharmaceutical products. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.
Technical Analysis
Honliv Healthcare Management Group Co Ltd
―
Human Health Holdings Ltd.
―
New Century Healthcare Holding Co. Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
UMP Healthcare Holdings Limited
―